Small Pharma (CVE:DMT) Share Price Falls 6.3% – What’s Next?

Small Pharma Inc. Share Price (CVE:DMT – Get Free Report ) was down 6.3% during trading on Friday. The stock traded as low as $0.15 and last traded at $0.15. 1,890,765 shares traded hands during trading, an increase of 538% from the average session volume of 296,159 shares. The stock had previously closed at $0.16.

Small pharma stock performance

The company’s 50-day simple moving average is $0.15 and its 200-day simple moving average is $0.15. The company has a current ratio of 2.63, a quick ratio of 6.28, and a debt-to-equity ratio of 5.95. The stock has a market cap of $50.37 million, a P/E ratio of -2.14 and a beta of 0.86.

About Small Pharma

(Get a free report)

Small Pharma Inc, a biotechnology company, focuses on developing short-acting psychedelic therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company’s product portfolio includes SPL026, which is in clinical phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in phase 1 clinical trial, as well as SPL801B, an oral dose.

Featured stories

Get news and reviews for Small Pharma Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Small Pharma and related companies with MarketBeat.com’s FREE daily email newsletter.